European Pharmaceutical Review

NOVEMBER 11, 2022

NTLA-2001, a novel CRISPR/Cas9-based therapy in the first-ever human gene editing trial ( NCT04601051 ) in vivo (in the body), reduced transthyretin (TTR) proteins by at least 90 percent in amyloidogenic transthyretin (ATTR) cardiomyopathy patients, 28 days after a single IV infusion, with benefits lasting four to six months.

Safety 102

Safety Medical Patients Transportation 102

European Pharmaceutical Review

JUNE 24, 2022

This suggests that any of the modelled changes to the regulation could lead to a decrease in the number of OMPs developed… Some of the assessed changes to the regulation could undermine the business model under which OMP?focused The actual legislation will then have a certain implementation period and will be prospective, for the most part.

Pharmaceutical 99

Pharmaceutical Medicine Marketing Competition 99

Map My Customers

NOVEMBER 19, 2022

Although Microsoft first introduced Dynamics in 2001, it has only lately started to become a serious competitor with other well-known CRMs. Some of the specific benefits of the platform include: 360-degree view of prospects and customers through in-depth analytics and predictive insights.

CRM 75

CRM Sales Prospecting B2B Sales 75

CloserIQ

OCTOBER 10, 2018

Drift provides a conversational sales and marketing platform that allows businesses to better connect with prospects and customers. They’ve worked with leading clients such as Twitter and Mercedes Benz. Founded 2001. Founded 2014. 51-100 employees. 107 million in funding. See open roles. Founded 2007. 501-1000 employees.

Sales 76

Sales Management Education Marketing 76